Restructuring: Evonik to Shut Down its Malonate Plant as Scheduled
Producing malonates, which are used primarily as precursors in the chemical, pharmaceutical, and perfume industries, is no longer profitable in Europe. The reasons are overcapacity and raw material prices, which are too high compared to those in other countries. In particular, businesses in China have intensified the competition. The employees who have been working in the malonate plant so far will be used in other production areas at the facility. Evonik currently employs about 600 people in Niederkassel.
Most read news
Organizations
Other news from the department manufacturing
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.